Innovent Highlights Bispecific Antibody Pipeline at ATS and ARVO 2026
SAN FRANCISCO and SUZHOU, China, May 18, 2026 Innovent Biologics presented new clinical and preclinical data from its next-generation...
ARVO 2026
Advertisement
Renerva Implants First PNM-CAP Device for Neuroma Pain
PITTSBURGH, May 13, 2026 Renerva, Inc. announced the successful first-in-human implantation of its investigational PNM-CAP™ device, marking a major...
Astellas Reports IZERVAY Reduced Vision Decline in GA Patients
NORTHBROOK, Ill., May 12, 2026 Astellas Pharma US announced new clinical findings showing that IZERVAY® (avacincaptad pegol intravitreal solution)...
Beacon Therapeutics Reports Positive XLRP Gene Therapy Data
LONDON and CAMBRIDGE, Mass., May 7, 2026 Beacon Therapeutics announced encouraging 12-month safety and efficacy results from its ongoing...
Atsena Therapeutics Reports Positive Gene Therapy Data at ARVO 2026
DURHAM, N.C., May 7, 2026 Atsena Therapeutics announced positive new clinical data from its investigational gene therapy programs ATSN-201...
Advertisements
Opus Genetics Showcases IRD Gene Therapy Progress at ARVO 2026
RESEARCH TRIANGLE PARK, N.C., May 7, 2026 Opus Genetics announced new clinical and preclinical data presentations at the 2026...
Drug Farm Reports DF-003 ROSAH Syndrome Data at ARVO
ALBANY, New York, United States and SHANGHAI, China – May 7, 2026 Drug Farm announced new ophthalmologic and central...
Everads Injector Shows Strong Results in Retinal Study
Tel Aviv, Israel | May 3, 2026 Everads Therapy has announced the publication of first-in-human clinical data for its...
Sydnexis, Inc. Advances SYD-101 Data in Myopia Trial
DEL MAR, California, May 1, 2026 Sydnexis, Inc. announced it will present new Phase 3 STAR trial data for...
Advertisement
